Manufacturer:

CSL Behring

Name:

HAEGARDA

Category:

J Code

HCPCS:

J0599

NDC(s):

63833-0828-02, 63833-0829-02,

Primary Type:

C1 Esterase Inhibitor

Route of Administration:

Subcutaneous

About:

HAEGARDA is a C1 Esterase Inhibitor drug manufactured by CSL Behring and administered via the Subcutaneous route of administration. The J Code: J0599 is aligned to the drug HAEGARDA.